Halozyme Therapeutics | HALO - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Cytokinetics USD 9.16B 975M 2026-05
DBV Technologies USD 274M 17M 2025-09
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 8.56B 905M 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
MannKind USD 965M 208M 2026-05
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12